{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:15:39Z","timestamp":1787008539095,"version":"build-2736575974"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Intramural Research Program"},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hannah\u2019s Hope Fund","award":["T32 AR 56993\u20134"],"award-info":[{"award-number":["T32 AR 56993\u20134"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Giant axonal neuropathy (GAN) is an ultra-rare autosomal recessive, progressive neurodegenerative disease with early childhood onset that presents as a prominent sensorimotor neuropathy and commonly progresses to affect both the PNS and CNS. The disease is caused by biallelic mutations in the GAN gene located on 16q23.2, leading to loss of functional gigaxonin, a substrate specific ubiquitin ligase adapter protein necessary for the regulation of intermediate filament turnover.<\/jats:p>\n                  <jats:p>Here, we report on cross-sectional data from the first study visit of a prospectively collected natural history study of 45 individuals, age range 3\u201321\u2009years with genetically confirmed GAN to describe and cross-correlate baseline clinical and functional cohort characteristics.<\/jats:p>\n                  <jats:p>We review causative variants distributed throughout the GAN gene in this cohort and identify a recurrent founder mutation in individuals with GAN of Mexican descent as well as cases of recurrent uniparental isodisomy. Through cross-correlational analysis of measures of strength, motor function and electrophysiological markers of disease severity, we identified the Motor Function Measure 32 to have the strongest correlation across measures and age in individuals with GAN. We analysed the Motor Function Measure 32 scores as they correspond to age and ambulatory status. Importantly, we identified and characterized a subcohort of individuals with a milder form of GAN and with a presentation similar to Charcot\u2013Marie\u2013Tooth disease. Such a clinical presentation is distinct from the classic presentation of GAN, and we demonstrate how the two groups diverge in performance on the Motor Function Measure 32 and other functional motor scales. We further present data on the first systematic clinical analysis of autonomic impairment in GAN as performed on a subset of the natural history cohort.<\/jats:p>\n                  <jats:p>Our cohort of individuals with genetically confirmed GAN is the largest reported to date and highlights the clinical heterogeneity and the unique phenotypic and functional characteristics of GAN in relation to disease state. The present work is designed to serve as a foundation for a prospective natural history study and functions in concert with the ongoing gene therapy trial for children with GAN.<\/jats:p>","DOI":"10.1093\/brain\/awab179","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T15:20:23Z","timestamp":1623252023000},"page":"3239-3250","source":"Crossref","is-referenced-by-count":37,"title":["Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort"],"prefix":"10.1093","volume":"144","author":[{"given":"Diana X","family":"Bharucha-Goebel","sequence":"first","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"},{"name":"Children's National Hospital, Division of Neurology, Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Norato","sequence":"additional","affiliation":[{"name":"National Institutes of Health, National Institute of Neurological Disorders and Stroke, Clinical Trials Unit, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimah","family":"Saade","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Paredes","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Biancavilla","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Rehabilitation Medicine Department, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Donkervoort","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupleen","family":"Kaur","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Lehky","sequence":"additional","affiliation":[{"name":"National Institutes of Health, EMG Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Fink","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Armao","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA"},{"name":"Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Waite","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Rehabilitation Medicine Department, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3826-5747","authenticated-orcid":false,"given":"Sarah","family":"Debs","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-0665","authenticated-orcid":false,"given":"Gilberto","family":"Averion","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadih M","family":"Zein","sequence":"additional","affiliation":[{"name":"National Institutes of Health, National Eye Institute, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Reghan","family":"Foley","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minal","family":"Jain","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Rehabilitation Medicine Department, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten G","family":"B\u00f6nnemann","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Neuromuscular and Neurogenetic Disorders of Childhood Section, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"issue":"3","key":"2021120109191215600_awab179-B1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/81701","article-title":"The gene encoding gigaxonin, a new member of the cytoskeletal BTB\/Kelch repeat family, is mutated in giant axonal neuropathy","volume":"26","author":"Bomont","year":"2000","journal-title":"Nat Genet"},{"issue":"8","key":"2021120109191215600_awab179-B2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.nmd.2007.03.012","article-title":"Genotype-phenotype analysis in subjects with giant axonal neuropathy (GAN)","volume":"17","author":"Koop","year":"2007","journal-title":"Neuromusc Disord"},{"issue":"3","key":"2021120109191215600_awab179-B3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00686905","article-title":"Giant axonal neuropathy \u2013 A unique case with segmental neurofilamentous masses","volume":"20","author":"Asbury","year":"1972","journal-title":"Acta Neuropath"},{"issue":"6","key":"2021120109191215600_awab179-B4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1542\/peds.49.6.894","article-title":"Giant axonal neuropathy","volume":"49","author":"Berg","year":"1972","journal-title":"Pediatrics"},{"issue":"2","key":"2021120109191215600_awab179-B5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mus.23306","article-title":"Proteomic analysis in giant axonal neuropathy: New insights into disease mechanisms","volume":"46","author":"Mussche","year":"2012","journal-title":"Muscle Nerve"},{"issue":"5","key":"2021120109191215600_awab179-B6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/hmg\/ddu556","article-title":"Intermediate filament protein accumulation in motor neurons derived from giant axonal neuropathy iPSCs rescued by restoration of gigaxonin","volume":"24","author":"Johnson-Kerner","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2021120109191215600_awab179-B7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/088307389000500316","article-title":"Giant axonal neuropathy: Clinical, electrophysiologic, and neuropathologic features in two siblings","volume":"5","author":"Kumar","year":"1990","journal-title":"J Child Neurol"},{"issue":"4-5","key":"2021120109191215600_awab179-B8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.brainresbull.2009.06.004","article-title":"Neuronal intermediate filaments in neurodegenerative disorders","volume":"80","author":"Perrot","year":"2009","journal-title":"Brain Res Bull"},{"issue":"2","key":"2021120109191215600_awab179-B9","first-page":"227","article-title":"Immunocytochemical studies of intermediate filament aggregates and their relationship to microtubules in cultured skin fibroblasts from subjects with giant axonal neuropathy","volume":"31","author":"Pena","year":"1983","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"2021120109191215600_awab179-B10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.410220118","article-title":"Giant axonal neuropathy: Correlation of clinical findings with post mortem neuropathology","volume":"22","author":"Thomas","year":"1987","journal-title":"Ann Neurol"},{"issue":"5","key":"2021120109191215600_awab179-B11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00018-007-6396-4","article-title":"Giant axonal neuropathy","volume":"64","author":"Yang","year":"2007","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"2021120109191215600_awab179-B12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.braindev.2014.12.002","article-title":"Giant axonal disease: Report of eight cases","volume":"37","author":"Incecik","year":"2015","journal-title":"Brain and Development"},{"issue":"5","key":"2021120109191215600_awab179-B13","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejmg.2008.05.006","article-title":"Clinical, pathological and molecular findings in two siblings with giant axonal neuropathy (GAN): Report from India","volume":"51","author":"Nalini","year":"2008","journal-title":"Eur J Med Gen"},{"issue":"3","key":"2021120109191215600_awab179-B14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00691706","article-title":"Giant axonal neuropathy. Involvement of peripheral nerve, myenteric plexus and extra-neuronal area","volume":"39","author":"Gambarelli","year":"1977","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2021120109191215600_awab179-B15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10286-016-0365-7","article-title":"Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: Implications for human disease","volume":"26","author":"Armao","year":"2016","journal-title":"Clin Auton Res"},{"issue":"5 Suppl 1","key":"2021120109191215600_awab179-B16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1590\/abd1806-4841.20164677","article-title":"Pili canaliculi as manifestation of giant axonal neuropathy","volume":"91","author":"Almeida","year":"2016","journal-title":"Na Bras Dermatol"},{"issue":"6","key":"2021120109191215600_awab179-B17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0883073814542946","article-title":"Measuring disease progression in giant axonal neuropathy: Implications for clinical trial design","volume":"30","author":"Roth","year":"2015","journal-title":"J Child Neurol"},{"issue":"3","key":"2021120109191215600_awab179-B18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejpn.2012.10.012","article-title":"A novel mutation in the GAN gene causes an intermediate form of giant axonal neuropathy in an Arab-Israeli family","volume":"17","author":"Abu-Rashid","year":"2013","journal-title":"Eur J Paediatric Neurology"},{"issue":"1","key":"2021120109191215600_awab179-B19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jmri.21425","article-title":"3T MR with diffusion tensor imaging and single-voxel spectroscopy in giant axonal neuropathy","volume":"28","author":"Brenner","year":"2008","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"2021120109191215600_awab179-B20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/0883073814547721","article-title":"Giant axonal neuropathy","volume":"30","author":"Vijaykumar","year":"2015","journal-title":"J Child Neurol"},{"issue":"3","key":"2021120109191215600_awab179-B21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.braindev.2015.09.001","article-title":"A mild case of giant axonal neuropathy without central nervous system manifestation","volume":"38","author":"Koichihara","year":"2016","journal-title":"Brain Dev"},{"issue":"4","key":"2021120109191215600_awab179-B22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.nmd.2009.01.011","article-title":"Phenotypic variability in giant axonal neuropathy","volume":"19","author":"Tazir","year":"2009","journal-title":"Neuromusc Disord"},{"issue":"10","key":"2021120109191215600_awab179-B23","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1177\/0883073812467688","article-title":"Giant axonal neuropathy caused by a novel compound heterozygous mutation in the gigaxonin gene","volume":"28","author":"Xu","year":"2013","journal-title":"J Child Neurol"},{"issue":"1","key":"2021120109191215600_awab179-B24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12881-016-0343-x","article-title":"Novel homozygous missense mutation in GAN associated with Charcot-Marie-Tooth disease type 2 in a large consanguineous family from Israel","volume":"17","author":"Aharoni","year":"2016","journal-title":"BMC Med Genet"},{"key":"2021120109191215600_awab179-B25","doi-asserted-by":"crossref","first-page":"P1.282","DOI":"10.1212\/WNL.84.14_supplement.P1.282","article-title":"Normative values for sudomotor axon reflex testing using QWEAT","volume":"84","author":"Sletten","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"2021120109191215600_awab179-B26","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.clinph.2015.07.037","article-title":"Tilt table testing in neurology and clinical neurophysiology","volume":"127","author":"Saal","year":"2016","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"2021120109191215600_awab179-B27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1085-9489.2005.0010206.x","article-title":"History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation","volume":"10","author":"Dyck","year":"2005","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl 1","key":"2021120109191215600_awab179-B28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jnc.12318","article-title":"Monitoring progression in Friedreich ataxia (FRDA): The use of clinical scales","volume":"126","author":"Burk","year":"2013","journal-title":"J Neurochem"},{"issue":"7","key":"2021120109191215600_awab179-B29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","article-title":"A motor function measure for neuromuscular diseases. Construction and validation study","volume":"15","author":"Berard","year":"2005","journal-title":"Neuromusc Disord"},{"issue":"11","key":"2021120109191215600_awab179-B30","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.apmr.2014.06.005","article-title":"Rasch analysis of the motor function measure in patients with congenital muscle dystrophy and congenital myopathy","volume":"95","author":"Vuillerot","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"issue":"143","key":"2021120109191215600_awab179-B31","doi-asserted-by":"crossref","DOI":"10.3791\/58784","article-title":"Measures of motor function and other clinical outcome parameters in ambulant children with Duchenne muscular dystrophy","author":"Nagy","year":"2019","journal-title":"J Vis Exp"},{"key":"2021120109191215600_awab179-B32","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1016\/j.nmd.2015.06.354","article-title":"Comparison of two clinical motor scales in individuals with giant axonal neuropathy (GAN)","volume":"25","author":"Waite","year":"2015","journal-title":"Neuromusc Disord"},{"issue":"10","key":"2021120109191215600_awab179-B33","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10072-015-2278-y","article-title":"Translation and linguistic validation of the composite autonomic symptom score COMPASS 31","volume":"36","author":"Pierangeli","year":"2015","journal-title":"Neurol Sci"},{"issue":"1","key":"2021120109191215600_awab179-B34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jtos.2018.09.006","article-title":"The ocular surface in children: A review of current knowledge and meta-analysis of tear film stability and tear secretion in children","volume":"17","author":"Chidi-Egboka","year":"2019","journal-title":"Ocul Surf"},{"issue":"3","key":"2021120109191215600_awab179-B35","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1542\/peds.2004-1678","article-title":"Pediatric Fabry disease","volume":"115","author":"Ries","year":"2005","journal-title":"Pediatrics"},{"issue":"5","key":"2021120109191215600_awab179-B36","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1023\/A:1026608630301","article-title":"Autonomic dysfunction in children with Hirschsprung\u2019s Disease","volume":"44","author":"Staiano","year":"1999","journal-title":"Dig Dis Sci"},{"issue":"8","key":"2021120109191215600_awab179-B37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.apmr.2013.01.014","article-title":"the MFM Spinal Muscular Atrophy Study Group","volume":"94","author":"Vuillerot","year":"2013","journal-title":"Arch Phys Med Rehab"},{"issue":"7","key":"2021120109191215600_awab179-B38","doi-asserted-by":"crossref","first-page":"e0201004","DOI":"10.1371\/journal.pone.0201004","article-title":"Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study","volume":"13","author":"Chabanon","year":"2018","journal-title":"PLoS ONE"},{"issue":"21","key":"2021120109191215600_awab179-B39","doi-asserted-by":"crossref","first-page":"e1932","DOI":"10.1212\/WNL.0000000000008517","article-title":"Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophies","volume":"93","author":"Jain","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"2021120109191215600_awab179-B40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12519-018-0140-z","article-title":"Two novel mutations in the GAN gene causing giant axonal neuropathy","volume":"14","author":"Normendez-Mart\u00ednez","year":"2018","journal-title":"World J Pediatr"},{"issue":"2","key":"2021120109191215600_awab179-B41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.24953\/turkjped.2019.02.019","article-title":"Giant axonal neuropathy: A differential diagnosis of consideration","volume":"61","author":"Edem","year":"2019","journal-title":"Turk J Pediatr"},{"issue":"4","key":"2021120109191215600_awab179-B42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/cge.12455","article-title":"Atypical giant axonal neuropathy arising from a homozygous mutation by uniparental isodisomy","volume":"87","author":"Miyatake","year":"2015","journal-title":"Clin Genet"},{"issue":"5","key":"2021120109191215600_awab179-B43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ajhg.2019.09.016","article-title":"Characterization of prevalence and health consequences of Uniparental Disomy in four million individuals from the general population","volume":"105","author":"Nakka","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"8","key":"2021120109191215600_awab179-B44","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0960-8966(00)00141-3","article-title":"Charcot-Marie-Tooth 2-like presentation of an Algerian family with giant axonal neuropathy","volume":"10","author":"Zemmouri","year":"2000","journal-title":"Neuromusc Disord"},{"issue":"5","key":"2021120109191215600_awab179-B45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0960-8966(01)00193-6","article-title":"Reference values of maximum isometric muscle force obtained in 270 children aged 4-16 years by hand-held dynamometry","volume":"11","author":"Beenakker","year":"2001","journal-title":"Neuromuscul Disord"},{"issue":"16","key":"2021120109191215600_awab179-B46","doi-asserted-by":"crossref","first-page":"e1852","DOI":"10.1212\/WNL.0000000000007319","article-title":"X-linked myotubular myopathy: A prospective international natural history study","volume":"92","author":"Annoussamy","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"2021120109191215600_awab179-B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000275252","article-title":"Schirmer\u2019s Test: Its normal values and clinical significance","volume":"38","author":"Gontier","year":"1976","journal-title":"J Otorhinolaryngol Relat Spec"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awab179\/41109144\/awab179.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/144\/10\/3239\/41381706\/awab179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/144\/10\/3239\/41381706\/awab179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T10:13:44Z","timestamp":1725185624000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/144\/10\/3239\/6296587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,6,11]]},"published-print":{"date-parts":[[2021,11,29]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awab179","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,6,11]]}}}